公共医疗体系中诊室活检与全麻活检对口咽鳞癌的比较
该研究比较了公共医疗体系中口咽鳞癌患者接受诊室活检与全麻panendoscopy引导活检的治疗延迟、费用和管理影响。全麻组肿瘤更小(平均29.4 mm vs 36.6 mm),但治疗启动延迟更长(平均70.1天 vs 44.5天),且未检出额外同步肿瘤,平均额外费用为2025加元3886元。结论认为临床可行时诊室活检应优先。
要点
- 全麻panendoscopy组治疗启动平均延迟70.1天,诊室组为44.5天。
- 全麻panendoscopy未检出任何额外同步肿瘤。
- 全麻panendoscopy平均额外费用为2025加元3886元。
核心结论
- 口咽鳞癌全麻panendoscopy活检延长治疗启动时间、增加费用,且不提高同步肿瘤检出,临床可行时应优先诊室活检。
研究设计与样本
- 回顾性比较研究,纳入2010至2024年间在两个大型三级中心接受根治性放疗或放化疗的口咽鳞癌患者。
- 诊室活检组37例,全麻panendoscopy组36例。
主要发现
- 两组人口学和肿瘤特征可比,但panendoscopy组肿瘤更小(平均29.4 mm vs 36.6 mm,差值-7.2 mm,95%CI -11.3至-3.1)。
- panendoscopy组治疗启动延迟更长(平均70.1天 vs 44.5天,差值25.7天,95%CI 13.0至38.2)。
- panendoscopy未检出额外同步肿瘤,平均额外费用为2025加元3886元。
临床怎么用
- 对于口咽鳞癌,当临床条件允许时,应优先选择诊室活检以缩短治疗启动时间并降低费用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We compared treatment delays, costs, and management impact between oropharyngeal squamous cell carcinoma (OPSCC) patients undergoing in-office versus general anesthesia panendoscopy-guided biopsies in two large tertiary centers in a public healthcare system. METHODS: All OPSCC patients included were treated between 2010 and 2024 with either curative radiation alone or chemoradiation. RESULTS: Demographic and tumor characteristics were comparable, except for smaller tumors in the panendoscopy group (n = 36) compared to the in-office group (n = 37) (mean size; 29.4 mm vs. 36.6 mm, respectively; difference -7.2 mm [95% CI, -11.3 to -3.1]). The panendoscopy group experienced substantially longer treatment initiation delays (mean days; 70.1 days vs. 44.5 days; difference 25.7 days [95% CI 13.0 to 38.2]). No additional synchronous tumors were detected through panendoscopy. Panendoscopy incurred a mean additional cost of 2025CAD $3886. CONCLUSIONS: Panendoscopy for OPSCC prolongs treatment initiation, incurs additional expenses, and provides no incremental synchronous tumor detection. When clinically feasible, in-office biopsies should be preferred.
引用
- Bellavance S, Khoury M, Colivas J, et al. Comparison of In-Office and General Anesthesia Biopsies for Oropharyngeal Squamous Cell Carcinoma in a Public Healthcare System. Head Neck. 2026. PMID: 42049677. doi:10.1002/hed.70300
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。